Navigation Links
Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
Date:5/17/2010

heavily treated patient population, where demonstrating benefit can be more difficult."

"I am impressed with both the strength and quality of the data from this Aeroquin trial", stated Dr. Patrick Flume, Professor of Medicine and Pediatrics at the Medical University of South Carolina and Co-Chair of the Pulmonary Guidelines Committee of the Cystic Fibrosis Foundation. "Importantly, Aeroquin represents a new class of inhaled antibiotics for the treatment of CF.  If we are to achieve our treatment objective of reducing bacterial exacerbations over the long term, it is critical that chronically infected patients be treated frequently with inhaled antibiotics.  Having multiple classes of aerosol antibiotics available will give clinicians the ability to rotate classes and tailor treatment to the needs of each individual patient.  Clinicians believe this is the best way to maximize efficacy and tolerability while minimizing resistance and side effects over the long term."

Mpex has been cleared to proceed to Phase 3 trials with Aeroquin by the U.S. FDA and is scheduled to meet with European regulatory authorities later this quarter.  Phase 3 studies are expected to begin shortly thereafter.

About Cystic Fibrosis

Patients with CF suffer from chronic infections of the lower respiratory tract that can be caused by multiple bacteria, including Pseudomonas aeruginosa. Chronic pulmonary infection is associated with a decrease in lung function over time caused by inflammation arising from bacteria and their toxins. Periodic exacerbations in the lung result from bacterial overgrowth (requiring antibacterial intervention), and these exacerbations are implicated as a major cause of morbidity and mortality in CF patients.  

'/>"/>
SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
2. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
3. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
4. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
5. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
6. Jazz Pharmaceuticals Announces Public Offering of Common Stock
7. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
8. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
9. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on May 17
10. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
11. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Nuclear medicine market is estimated to ... Nuclear are drugs that contain radionuclide-emitting ionization radiation, ... and treat diseases. Increasing incidences of ... and ready availability of radiopharmaceuticals are the major ... awareness and use of SPECT and PET also ...
(Date:9/23/2014)...   LabStyle Innovations Corp . (OTCQB: DRIO), ... announced that it has closed a $4.2 million ... stock and warrants.  No placement agent was used ... expects to secure net proceeds of approximately $4.1 ... intends to use the net proceeds from the ...
(Date:9/23/2014)... YORK , September 23, 2014 /PRNewswire/ ... solution Face2Gene améliorée lors d,une série de ... ), pionnier dans le domaine de l,analyse ... sa solution au stand n° 1035 lors de ... San Diego , en ...
Breaking Medicine Technology:Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 2LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 3LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 4LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 5FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3
... Potential of microRNAs as,Novel Cancer Drug Targets, REHOVOT, ... 2007,/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , a leading ... Cell by scientists from the Weizmann Institute of ... potential for a,specific, single microRNA (miR-34a) to be ...
... endpoint achieved -- , LAINATE, Italy - July ... positive preliminary results from its,phase II/III study with ... a broad spectrum, semi-synthetic,antibiotic that is not absorbed ... Cosmo's MMX(tm) technology, which delivers the active,ingredient into ...
Cached Medicine Technology:Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 2Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 3Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 4Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 5Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2
(Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
(Date:9/23/2014)... medicine is rapidly developing, bringing with its advances ... optimize prevention and treatment interventions. Genetic tests ... virus (HIV) and hepatitis c virus (HPC), and ... used to screen for an individual,s susceptibility to ... for addiction. , While there appear to be ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 What: ... Manhattan’s Upper West Side that embodies the inclusion ... Eden: Christians, Scripture and the Ecological Crisis, a ... B. Rhodes Professor Emerita of Old Testament at ... for ancient wisdom that lends insight into current ...
(Date:9/23/2014)... Men who are already obese as teenagers could grow ... their peers of normal weight. So says Petter Lundborg ... Dan-olof Rooth of Linneas University and Lund University, all ... the United Kingdom and the United States, and the ... , The researchers analyzed large-scale data of 145,193 ...
(Date:9/23/2014)... Mission Viejo, California (PRWEB) September 23, 2014 ... in the Oracle services market. Included are ... Oracle Resource Augmentation. Trevera supports all versions of ... and associated point releases. , Trevera has ... specifically for organizations that need help with their ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Note to young men: Fat doesn't pay 2Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... the latest salvo in the pay-for-performance medicine, one of the ... plan to rate physicians on its network based on the ... means that patients will be allowed to choose the doctor ... patients. Naturally, doctors are not amused by this idea. United ...
... New Zealand President Murray Dear is not happy with the ... The statistics show that only 60% of diabetic patients // ... diabetics, which is a state, funded program. , ,The ... to the people that diabetics is not properly monitored it ...
... mats spread across the walls of a patient's room ... skin diseases, hypertension and rheumatic complaints, a study says.//,A ... said patients kept in medicated rooms were cured in ... ,The study involved 36 patients, of whom 19 ...
... to chill Chilling can result in bring on common cold ... also approves ratifies the conventional wisdom of mothers about cold. ... without a hat or with wet hair. Since the early ... the online edition of ABC News. , ,Ron Eccles, ...
... overcome from the crisis if a possible epidemic strikes ... flu strikes Japan it could cause more than 64,000 ... have a cabinet meeting next week to discuss various ... cabinet ministers to prepare preventive measures and emergency measures ...
... has attacked the health profession for complacency in its preparations ... a “biological inevitability”. //, ,Last week Donaldson called together ... colleges, to emphasize that the disease could kill between 50,000 ... joke. , He is planning to issue a “protect ...
Cached Medicine News:Health News:Now medicated coir to cure ailments 2Health News:Doctors attacked for complacency against pandemic threat 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: